Biomarkers

P013 - Metabolic Network Alterations In Multiple Sclerosis And Correlation With Disease Severity

Presenter
  • K. Fitzgerald
Author
  • K. Fitzgerald
  • E. Sotirchos
  • A. Filippatou
  • R. Rattan
  • M. Cerghet
  • L. Poisson
  • J. Graves
  • E. Waubant
  • E. Mowry
  • S. Giri
  • P. Calabresi
  • P. Bhargava
Session Title
Poster Session 1 / Opening Networking Event

Previous ePoster
P011 - Higher Sensitivity Of Quantitative RT-PCR Compared With Flow Cytometry For Quantification Of B Cells After Anti-CD20 Monoclonal Antibody Therapy

Next ePoster
P014 - Multi-layer Analysis Of Quantitative 7t Mri In The Cortex Of Multiple Sclerosis Patients Reveals Pathology Associated With Disability
P015 - Multivariate Protein Biomarker Models Better Predict Multiple Sclerosis Radiographic Disease Activity Compared To Serum Levels Of Nfl Alone
No Preview Available
P016 - No Effect Of Body Mass Index On Serum Neurofilament Light In Long Term Rituximab Treated Multiple Sclerosis Patients: The Need To Correct For Age, Blood Volume, And Disability
P017 - Serum Neurofilament Light Chain Levels as an Indicator of Treatment Response in CARE-MS I Patients
P018 - Serum Nfl Levels In First Five Years Correlate With 10-year Deep Gray Matter MRI Volumes In Multiple Sclerosis
P019 - Evaluation Of Evidence From Smart Phone Sensors And Patient-reported Outcomes In Persons With Multiple Sclerosis (ElevateMS)
P020 - Muscle Fatigue In People With Multiple Sclerosis Impairs Standing Balance
No Preview Available
P021 - A Longitudinal Study Of Objectively-measured Physical Activity Patterns In Multiple Sclerosis
P022 - Automated Identification OfQuantitative Susceptibility MappingRim + Lesions
No Preview Available
P023 - Central Nervous System Single Cell Profiling Of Transcriptomic Variations Associated With Multiple Sclerosis